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Abstract
Background: Headache is the most common neurological symptoms worldwide, as over 90% of people have
noted at least one headache during their lifetime. Tension-type headaches, cervicogenic headaches, and migraines
are common types of headache which can have a significant impact on social, physical, and occupational
functioning. Therapeutic management of headaches mainly includes physical therapy and pharmacological
interventions. Dry needling is a relatively new therapeutic approach that uses a thin filiform needle without
injectate to penetrate the skin and stimulate underlying tissues for the management of neuromusculoskeletal pain
and movement impairments.
The main objective of this systematic review and meta-analysis is to evaluate the effectiveness of dry needling in
comparison to other interventions on pain and disability in patients with tension-type headache, cervicogenic
headache, and migraine.
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Methods/design: We will focus on clinical trials with concurrent control group(s) and comparative observational
studies assessing the effect of dry needling in patients with tension-type headache, cervicogenic headache, and
migraine. Electronic databases from relevant fields of research (PubMed/ Medline, Scopus, Embase®, PEDro, Web of
Science, Ovid, AMED, CENTRAL, and Google Scholar) will be searched from inception to June 2019 using defined
search terms. No restrictions for language of publication or geographic location will be applied. Moreover, grey
literature, citation tracking, and reference lists scanning of the selected studies will be searched manually. Primary
outcomes of this study are pain intensity and disability, and secondary outcomes are cervical spine ROM, frequency
of headaches, health-related quality of life, and TrPs tenderness. Studies will be selected by three independent
reviewers based on prespecified eligibility criteria. Three reviewers will independently extract data in each eligible
study using a pre-piloted Microsoft Excel data extraction form. The assessment of risk of bias will be implemented
using the Cochrane Back and Neck Review Group 13-item criteria and NOS. Direct meta-analysis will be performed
using a fixed or random effects model to estimate effect size such as standardized mean difference (Morris’s dppc)
and 95% confidence intervals. Statistical heterogeneity will also be evaluated using the I2 statistic and the χ2 test. All
meta-analyses will be performed using Stata V.11 and V.14 softwares. The overall quality of the evidence for the
primary outcomes will be assessed using GRADE.
Discussion: All analyses in this study will be based on the previous published papers. Therefore, ethical approval
and patient consent are not required. The findings of this study will provide important information on the value of
dry needling for the management of tension-type headache, cervicogenic headache, and migraine.
Trial registration: PROSPERO registration number: CRD42019124125.
Keywords: Dry needling, Cervicogenic headache, Tension-type headache, Migraine, Systematic review, Meta-
analysis,
Background
Headache is a major health concern as one of the most
common type of all symptoms in the worldwide popula-
tion [1, 2]. According to the 2016 Global Burden Disease
study [3], “tension-type headache” and “migraine” which
are described as primary headache syndromes have the
third and sixth highest prevalence among 328 diseases
and injuries in 195 countries from 1990 to 2016. Halde-
man and Dagenais [4] reported that the prevalence of
tension-type headaches, migraines, chronic daily head-
aches, and cervicogenic headaches in the general popula-
tion is 38, 10, 3, and 0.4% to 2.5%.
Tension-type headache is identified by a bilateral
pressing or tightening quality (non-pulsating quality), a
mild to moderate intensity, and pain, which is not ag-
gravated by routine physical activity, in the absence of
vomiting, nausea, but may be accompanied by either
photophobia or phonophobia [5–8]. These symptoms,
however, do not present simultaneously during the same
episode [9]. This neurological disorder is more common
among female patients (female-to-man ratio of 5:4). The
peak prevalence occurs between the ages of 30 and 39
[10]. The International Headache Society [5] classifies
tension-type headache into three subtypes according to
headache frequency: infrequent episodic (< 1 day of head-
ache per month), frequent episodic (1–14 days of head-
ache per month), and chronic (≥15 days per month).
Despite extensive neurophysiological and clinical stud-
ies, the exact cause of tension-type headache remains
unknown [6, 7], however, peripheral nociceptive mecha-
nisms appear to be the main cause of episodic tension-
type headache, while chronic tension-type headache may
be caused by central sensitization, inadequate endogen-
ous pain control, and peripheral myofascial mechanisms
(myofascial nociception) [11–15]. Previous experimental
studies demonstrated that referred pain originating in
myofascial TrPs within neck and shoulder muscles and
surrounding soft tissues, such as fascia, tendons, and lig-
aments may reproduce headaches in patients with
tension-type headache [16–20]. TrPs can be defined as
hyperirritable palpable spots of taut fibers located within
a myofascial tissue, which have been known to cause
non-dermatomal referral pain and discomfort [21]. Mus-
cles which are commonly involved in tension-type head-
ache include the sub-occipital, sternocleidomastoid,
upper trapezius, levator scapula, splenius, temporalis,
and masseter [14, 22, 23].
Cervicogenic headache is characterized by chronic
pain that originates from bony structures or soft tissues
of the neck and is referred to the head [24]. The pain of
cervicogenic headache is usually unilateral with occipito-
frontal distribution of spread [25]. The prevalence of
cervicogenic headache has been estimated at 15–20% in
patients with chronic headaches [26]. The most accepted
mechanism of cervicogenic headache is convergence be-
tween the trigeminal nerve and C1–3 nerves in the trige-
minocervical nucleus [27]. The characteristics of
tension-type headache and cervicogenic headache are
Pourahmadi et al. Chiropractic & Manual Therapies           (2019) 27:43 Page 2 of 11
similar, however, according to the Cervicogenic Head-
ache International Study Group criteria [28] most cervi-
cogenic headaches can be differentiated from tension-
type headache and migraine with some overlap. In
addition, according to Linde et al. [29], some patients
may suffer from both types of headaches.
Migraine is defined as severe throbbing headache with
nausea or vomiting associated with photophobia, that is
aggravated by routine physical activity such as walking
or climbing stairs [30, 31]. Migraine typically lasts be-
tween 4 and 72 h and has unilateral location [31]. Des-
pite many migraine publications, the mechanism of
migraine is not yet well understood [32]. The mechan-
ism of migraine is believed to involve the trigeminal cer-
vicogenic complex, which receives nociceptive
information via afferent projections from the dura mat-
ter in large intracranial vessels [33]. A study conducted
by Florencio et al. [34] indicated that patients with mi-
graine exhibited active TrPs in their neck extensor mus-
cles. According to the IHS, migraine is diagnosed if a
person has at least 5 attacks fulfilling the abovemen-
tioned criteria [35].
Therapeutic management of headaches mainly com-
prises physical therapy and pharmacological approaches
[36–38]. In the last decade, there has been an increasing
interest in the use of dry needling for the treatment of
headache as well as for neck and shoulder pain syn-
dromes [38]. Dry needling is a skilled intervention fre-
quently performed by physical therapists, physicians,
chiropractors, and acupuncturists for the relief of myo-
fascial pain disorders [39, 40]. In this technique a fine
sterile needle is utilized to penetrate the skin, subcutane-
ous tissues, fascia, and muscle, with the goal of deacti-
vating TrPs without the use of an anesthetic [41]. Once
a TrP is deactivated, the fine needle is removed [42]. It is
an efficient, easy-to-learn-and-perform procedure with a
low risk profile [43]. Hong [44] suggested that local
twitch responses should be elicited during dry needling
for a successful technique; however, recent studies have
questioned this notion [45, 46]. The time of application
will rely upon the irritability of the TrP [38]. Although
dry needling might not change all central sensitization
aspects, it is probable that local and referred pain will be
reduced, muscle blood flow, oxygenation, patterns of
muscle activation, and range of motion will be improved,
and the biochemical environment of TrPs will be chan-
ged [47–49]. Linde et al. [50] reported that the physio-
logical mechanism of dry needling includes a
combination of peripheral effects (such as spinal [i.e.,
gate control] and supraspinal [i.e., endogenous opioid
system] mechanisms), as well as cortical effects (such as
psychological or placebo mechanisms). It is hypothesized
that dry needling may activate the serotonergic (5-HT)
and noradrenergic descending inhibitory systems, which
in turn may decrease pain [48]. Furthermore, Cagnie et
al. [48] hypothesized that dry needling, via stimulation
of the nociceptive fibers, may stimulate the enkephali-
nergic inhibitory dorsal horn interneurons. It is unclear
whether the needle manipulation or the electrical stimu-
lation is responsible for these results or both [48].
To the best of our knowledge, a systematic review
conducted by France et al. [6] has investigated the effect-
iveness of dry needling and conventional physiotherapy
in the management of cervicogenic headache or tension-
type headache. Ten electronic databases were searched
up to October 2012 and three relevant studies (two clin-
ical trials and one case report) were identified through
searches. Two included clinical trials with tension-type
headache participants (40 male and 35 female) demon-
strated statistically significant improvements following
dry needling, but no significant differences between
groups [6]. Furthermore, one case report study with a
cervicogenic headache female that was included in the
systematic review showed significant improvement in
pain and neck disability index after nine treatment ses-
sions of dry needling combined with manual therapy [6].
A formal meta-analysis was not performed because the
number of studies included was not enough [6]. Add-
itionally, grey literature was not included in the former
systematic review to assure the comprehensiveness of
the search strategy [6]. Although no systematic review
and meta-analysis studies have been conducted to evalu-
ate the effectiveness of dry needling on headache, several
Cochrane systematic review studies have looked at the
effectiveness of acupuncture in headaches [29, 50, 51].
In 2016, Linde et al., [29] investigated whether acupunc-
ture is more effective than routine care, than ‘sham’ acu-
puncture; and other interventions in reducing headache
frequency in adults with episodic or chronic tension-
type headache. Twelve randomized trials with 2349 par-
ticipants (median 56, range 10 to 1265) were included in
the present systematic review and the results indicated
that acupuncture is effective for treating frequent epi-
sodic or chronic tension-type headaches, but further tri-
als - particularly comparing acupuncture with other
treatment options such as physical therapy, massage or
exercise - are needed [29]. In another systematic review,
Linde et al. [51] assessed the effectiveness of acupunc-
ture in reducing headache frequency in patients with mi-
graine. Twenty-two trials with 4419 participants (median
42, range 27 to 1715) were included and the results
showed that there was consistent evidence that acupunc-
ture provides additional benefit to treatment of acute
migraine attacks only or to routine care. However, Linde
et al. [51] found no evidence for an effect of ‘true’ acu-
puncture over ‘sham’/‘placebo’ acupuncture. Moreover, it
has been suggested that acupuncture is at least as effect-
ive as, or possibly more effective than, prophylactic drug
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treatment, and has fewer adverse effects [51]. Finally,
Linde et al. [51] concluded that acupuncture should be
considered a treatment option for patients with migraine
willing to undergo this treatment.
Despite the widespread use of dry needling in the
treatment of headaches, its effectiveness is still contro-
versial when compared with other techniques. Further-
more, because the previous published systematic review
on this topic is out of date, a new systematic review of
the literature is needed. Hence, the main objective of
this systematic review and meta-analysis is to evaluate
the effectiveness of dry needling in comparison to other
interventions on pain and disability in patients with
tension-type headache, cervicogenic headache, and
migraine.
Methods
This systematic review will be performed in accordance
with the PRISMA statement [52] and principles outlined
in the Cochrane Handbook for Systematic Reviews of In-
terventions [53]. This protocol has been prepared with
regard to the PRISMA-P 2015 guidelines [54] and was
registered on PROSPERO (International Prospective
Register of Systematic Reviews, http://www.crd.york.ac.
uk/PROSPERO/; #CRD42019124125) in 4 March 2019.
Ethical approval and patient consent will not be required
since this is a systematic review of previously published
studies and no new data collection will be undertaken.
Search strategy and study selection
A comprehensive electronic database search will be per-
formed from inception to June 31, 2019 on the following
databases: Medline (NLM) via the PubMed, Scopus,
Embase®, PEDro, Web of Science, Ovid, AMED via the
EBSCO, CENTRAL via The Cochrane Library, and Goo-
gle Scholar. Electronic search strategies are constructed
based on the combined keywords: tension-type head-
ache, cervicogenic headache, migraine, and dry needling
to identify human studies in the literature that investi-
gated the effectiveness of dry needling in adult patients
(≥ 18 years) with tension-type headache, cervicogenic
headache, or migraine. A combination of MeSH (Med-
line), Emtree (Embase®) terms, and free text words in re-
search equations with ‘OR’ and ‘AND’ Boolean operators
will be used. Free text words will be selected from the
indexed keywords of most relevant original studies and
reviews in Scopus. To retrieve all possible variations of a
specific root word, wildcards, and truncations will also
be applied. The search strategy is customized according
to the database being searched. In addition, if additional
keywords of relevance are detected during electronic
searches we will modify and re-formulate the search
strategies to incorporate these terms. Three authors
(M.R.P., M.A.M.B., and M.B.) will develop the sufficient
search syntax, and after piloting and finalizing it, the
search of the electronic databases will be conducted by
one author (M.R.P.). Moreover, we will consult a bio-
medical librarian to review our search strategy using the
PRESS 2015 guideline evidence-based checklist [55] in
order to minimize error in our search strategies. Details
of PubMed/Medline (NLM) database search syntax are
presented in Additional file 1. PubMed’s ‘My NCBI’ (Na-
tional Center for Biotechnology Information) email alert
service will be employed for identification of newly pub-
lished systematic reviews using a basic search strategy.
Citation tracking and reference lists scanning of the
selected studies and relevant systematic reviews will be
searched for eligible studies. Manual search of keywords
via internet will be also conducted. Additionally, the
table of contents of the journal of Cephalalgia and the
Journal of Bodywork & Movement Therapies will be
reviewed. The key journals are identified within the re-
search in the Web of Science and Scopus. To minimize
publication bias, grey literature will be identified by
searching for conference proceedings (via ProQuest,
Scopus, and Web of Science Conference Proceedings
Citation Index database), unpublished masters and doc-
toral theses (via ProQuest and OpenGrey; System for In-
formation on Grey Literature in Europe), and
unpublished trials (via US National Institutes of Health
Ongoing Trials Register [ClinicalTrials.gov], WHO
International Clinical Trials Registry Platform, and Inter-
national Standard Randomized Controlled Trials Num-
ber [ISRCTN]. Abstracts from the annual meeting of
American Headache Society and European Headache
Federation congress in the last 5 years and abstracts
from the congress of the International Headache Society
in the last 4 years will also be searched. In addition, ex-
perts with clinical and research experience on the role of
dry needling for headaches will be consulted. Finally,
one author (M.R.P.) will complete the search process by
manual searching in Google. We will not review content
from file sources that are from mainstream publishers
(e.g., BMJ, Sage, Wiley, ScienceDirect, Springer, and Tay-
lor & Francis), as we expect these to be captured in our
broader search strategy.
If a full text of a relevant article is not accessible, a
contact will be made with the corresponding author(s).
In addition, when unpublished works are retrieved in
our search, an email will be sent to the corresponding
author(s) to determine whether the work has been sub-
sequently published. If no response received from the
corresponding author(s) after three emails, the study will
be excluded.
Eligibility criteria
All publications identified by the searches will be
imported into the EndNote reference management
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software (version X9.1; Clarivate Analytics Inc., Philadel-
phia, PA, USA), and duplicates will be removed auto-
matically and double-checked manually. The titles and
abstracts of each citation will be screened independently
by three reviewers (M.R.P. M.A.M.B., and M.B.) accord-
ing to a checklist that is developed for this purpose
(Table 1) with the following criteria:
1- Study design should be clinical trials with
concurrent comparison group(s) or comparative
observational studies;
2- Study participants should have at least one of the
three types of headache (tension-type headache,
cervicogenic headache, and/or migraine);
3- Study participants should be ≥18 years of age;
4- The studies should have at least one of the
primary outcomes (i.e., pain and disability) of
this review; and,
5- Dry needling should be the main intervention in
the study.
If a study meets all of the criteria, then the full-text of
the study will be assessed for eligibility. In addition, a
full-text review will be undertaken if the title and ab-
stract do not provide adequate information. The selec-
tion process will be conducted strictly according to the
inclusion and exclusion criteria by three independent re-
viewers simultaneously (M.R.P., M.A.M.B., and M.B.)
(Table 1). The three reviewers are physical therapists
with experience in performing systematic reviews. Dis-
agreements will be resolved by discussion and if neces-
sary, consultation with a fourth reviewer (A.A.K.). The
eligibility criteria are based on the PICOS acronym
(Table 1) and will be piloted prior to conducting the re-
view proccess. The entire process of study selection is
summarized in the PRISMA flow diagram (Fig. 1).
Table 1 PICOS criteria for the study
Criteria Inclusion
Population The population will comprise adult patients (≥ 18 years of age) of either gender with tension-type headache, cervicogenic headache, or migraine. Tension-
type headache, cervicogenic headache, and migraine diagnoses must be based on the International Classification of Headache Disorders [ICHD-3 beta 2013
[35] and its previous editions ICHD-2 2004 [5]] proposed by the International Headache Society. If no specified criteria were reported among the studies,
the diagnosis must be based on discriminable and important characteristics of tension-type headache, cervicogenic headache, and migraine disorders, as
confirmed by patients’ doctors. Important characteristics of tension-type headache include dull, aching, non-throbbing pain occurring in short episodes of
variable duration or continuously (chronic form) that can be distributed unilaterally or bilaterally and referred to temporal, parietal, occipital, or frontal re-
gions of the head without nausea, visual/auditory disturbances, or vomiting [56]. Important characteristics of cervicogenic headache include unilateral head-
ache with symptoms and signs of neck involvement, including impairment in cervical spine ROM and pain on palpation of the neck structures, especially
on the upper cervical spine [57]. However, patients with cervicogenic headache may have headache without neck pain [35]. Finally, important characteristics
of migraine attack include recurrent headache, unilateral pain, pulsating quality, moderate to severe intensity, in association with nausea and/or photopho-
bia and phonophobia and is aggravated by physical activity [58]. Studies in which children or adolescents were treated with dry needling technique will be
excluded from this systematic review.
Intervention Dry needling is a therapeutic procedure used in subjects with myofascial pain or motor dysfunction that comprises inserting thin filiform needle directly
into the skin, subcutaneous tissues, fascia, and muscle, with the intent to deactivate TrPs without the use of an anesthetic [59]. In this technique, the needle
usually moves in vertical direction at approximately 1 Hz with or without rotations [38]. Sometimes the needles may be left in place for approximately 20
min with or without manual stimulation [60]. Simons et al. [61] mentioned that dry needling targeting TrPs can disrupt the dysfunctional neuromuscular
activity in the muscles, decrease muscle tone, and normalize the neurochemical pathways of muscles. Because of the potential interchangeable use of
terms ‘dry needling’ and ‘acupuncture’ in the literature [6, 38], both search terms will be used. To be eligible for the review, an explicit explanation of the dry
needling intervention is required and needed to involve the insertion of fine needles precisely into identified TrPs with the aim of influencing headache
intensity or frequency [6]. Additionally, if in a study at least one local twitch response was obtained during a needling procedure, it will be considered as a
dry needling technique. No restriction for dosage of dry needling, frequency of treatment sessions, duration of intervention, and time to outcome measure
will be set. However, for an article to be included in this systematic review, it should have at least one session of dry needling for patients with tension-
type headache, cervicogenic headache, or migraine. We will exclude acupuncture studies in which the fine needle was only inserted into acupoints on the
neck, face, and head regions without obtaining at least one local twitch response. Furthermore, when dry needling is used combined with other treat-
ment(s) in primary studies, at least 50% of the total treatment programme is required to be presented for inclusion.
Comparator Other physical therapy/conservative interventions, different substances injections, pharmacological interventions, and sham or control group.
Outcomes The primary outcomes of this systematic review are pain and disability. These outcomes were selected as the primary outcomes, since pain and disability
are considered common patient reported outcomes.
Pain is defined as pain intensity, measured at the time point closest to the end of treatment [62]. Pain intensity may be assessed with a continuous self-
report scale (e.g., NPRS or VAS), a rating scale within a composite measure of pain (e.g., McGill Pain Questionnaire), or an ordinal scale with greater than six
levels (we will treat such ordinal scales as continuous variables). We will not exclude studies that use other measurement tools.
Functional disability is defined as any restriction or lack of ability to perform an activity in the manner or within the range considered normal for a human
[63]. Functional disability may be measured with a continuous, self-report scale (e.g., FRI), a rating scale within a composite measure (e.g., social functioning
scale in the Short Form-36), or an ordinal scale with greater than six levels (we will treat such ordinal scales as continuous variables). We will not exclude
studies that use other measurement tools.
For articles to be included, they should have at least one of the primary outcomes of this study. In addition, the secondary outcomes are cervical spine
ROM, frequency of headaches, health-related quality of life (e.g., Short Form-36), and TrPs tenderness. We will exclude any other clinical or health-related
outcomes from this review.
Study
Design
Clinical trials with concurrent comparison group(s) as well as comparative observational studies published in peer-reviewed journals will be included in the
present systematic review. Results obtained from other observational studies (i.e., cross-sectional and cohort studies without any comparison group(s)), opin-
ion pieces, editorials, systematic reviews, narrative reviews, case reports, book chapters, policy documents, commercial documents, and websites will be ex-
cluded. Qualitative studies will not be included. Studies including tension-type headache and migraine patients with medication-overuse history according
to the ICHD-3 beta criteria [35] will also be excluded. No restrictions for language of publication or geographic location will be applied. Articles published in
a non-English language will be translated appropriately by Bing Microsoft Translator (https://www.bing.com/translator).
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Data collection and analysis
Risk of bias
The risk of bias of each clinical trial will be evaluated in-
dependently by three reviewers (M.R.P., M.A.M.B., and
M.B.) using the Cochrane Back and Neck Review Group
13-item criteria [64]. The guideline examines six specific
domains of bias, and the scoring criteria for each item in
each of the domains are “Yes,” “No,” and “Unclear” if
there is insufficient information to make an accurate
judgment. We will categorize studies as “low risk” (at
least six of the 13 criteria are met) or “high risk” (less
than six criteria are met) [65]. In addition, the risk of
bias assessment of each comparative observational study
will be judged independently by the same reviewers
(M.R.P., M.A.M.B., and M.B.) on the basis of the NOS
[66]. The NOS is recommended by the Cochrane Non-
Randomized Studies Methods Working Group to assess
the quality of observational studies. The scale is based
on the following three subscales: Selection (4 items),
Comparability (1 item), and Outcome or Exposure (3
items) [67]. A total score of 3 or less will be considered
high, 4–6 will be considered moderate, and ≥ 7 will be
deemed low risk of bias [68]. Unacceptable bias will be
defined as a zero score in any of the NOS subscales. The
level of inter-rater agreement will be assessed using
weighted Cohen’s kappa coefficient, with a method devel-
oped for comparing the level of agreement with categorical
data along with their respective 95% confidence intervals
(κ 0–0.20 = poor agreement; 0.21–0.40 = fair agreement;
0.41–0.60 =moderate agreement; 0.61–0.80 = good agree-
ment; and 0.81–1 = very good agreement) [69]. Disagree-
ments will be resolved by discussion and where it is
required with input from a fourth reviewer (A.A.K).
The graphical presentation of assessment of risk of
bias will be generated by Review Manager Software
(RevMan V.5.3.5) or Stata V.14 (Sata Corp., College Sta-
tion, TX, USA).
Data extraction
Data extraction and abstraction from each eligible study
will be performed independently by three reviewers
(M.R.P., M.A.M.B., and M.B.), using a Microsoft Excel
spreadsheet (Microsoft, Redmond, Washington, USA)
which will be designed according to the Cochrane meta-
analysis guidelines and will be adjusted to the needs of
this review. The data-extraction form will be pilot-tested
before its use. Pilot testing will be performed on two
published studies which are not included in the present
systematic review but are relatively similar to the eligible
studies. During pilot-testing, we will assess the charac-
teristic of the variables (e.g., categorical or continuous)
and whether all pre-defined variables in the data-
extraction form are useful for the systematic review and
meta-analysis. Moreover, we will check if it is possible to
Fig. 1 Flow diagram of study selection process
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include additional variables in the data-extraction form
in order to perform further post-hoc sensitivity analyses.
The following data will be extracted from all the eligible
studies:
1. Study characteristics: first author’s name, journal’s
name, publication year, country of study
performance, study year, study design, single versus
multicenter, size of the sample, and duration of
follow-up.
2. Participants’ characteristics: ethnicity, age, gender,
body mass, stature, BMI, and type of headache.
3. Intervention and comparator details: sample size for
each treatment group, muscles name, features of
dry needling treatment (such as type of dry
needling [superficial or deep], needle size, needling
technique, and whether the technique elicited local
twitch response), features of control interventions
(sham/placebo methods or standard treatment
details), duration of treatment session, frequency of
treatment sessions per week or month, withdrawals,
dropouts, and any other relevant detail.
4. Outcome measures: pain intensity, scales and
questionnaires used to assess pain, total score of
functional disability, disability questionnaires,
cervical spine ROM, instruments used to measure
cervical spine ROM, questionnaire used to measure
health-related quality of life, and instruments used
to assess TrPs tenderness. Primary and secondary
outcomes will be documented at both baseline and
endpoint.
Following the completion of this process, one author
(M.R.P.) will double-check the extracted data to avoid
any omissions or inaccuracies.
Dealing with missing data
If there are missing data or insufficient details in relation
to the characteristics of the studies included in the
meta-analysis, we will try to contact the study authors
for further information. However, if the authors do not
respond to queries, we will apply the following strategies
to address missing data:
1- If ITT analyses were conducted in the eligible
studies, we will use the ITT data instead of missing
data as the first option.
2- For continuous missing outcome data, we will try
to re-calculate mean difference, standard deviation,
or effect size values when the test statistics, me-
dians, p-values, standard errors, or confidence inter-
vals are reported in the selected studies using the
Campbell Collaboration effect size calculator
(http://www.campbellcollaboration.org/escalc/html/
EffectSizeCalculator-SMD-main.php).
3- If required data are presented only in graphs of the
included studies, we will extract the data by using
WebPlotDigitizer V.4.2 (https://automeris.io/
WebPlotDigitizer/index.html).
4- If none of the above strategies can be implemented,
we will try to estimate mean difference and
standard deviation values from the most similar
study [65, 70].
Assessment of heterogeneity
Statistical heterogeneity among the included studies will
be assessed using the I2 statistic and Q test (χ2) as rec-
ommended by the Cochrane Handbook for Systematic
Reviews of Interventions [71]. The I2 statistic will be
interpreted using the following guide: 0–40% = no im-
portant heterogeneity; 30–60% =moderate heterogeneity;
50–90% = substantial heterogeneity; 75–100% = consider-
able heterogeneity [72]. Heterogeneity will be considered
before conducting pooled analysis. When I2 values are
higher than 50% and there is overlap between the confi-
dence intervals of the included studies with the sum-
mary estimate on the forest plot, the results of all
eligible studies will be combined. The potential sources
of heterogeneity will be explored by sensitivity and sub-
group analyses/meta-regression.
Assessment of publication bias
Publication bias will be explored by constructing funnel
plot and performing Begg and Mazumdar’s rank correl-
ation [73] and Egger’s linear regression tests [74]. A p-
value < 0.05 for Begg and Mazumdar’s rank correlation
and Egger’s linear regression tests indicates significant
statistical publication bias. However, the p-value will be
set at 0.10 if the number of included studies is < 10.
Moreover, Duval and Tweedie ‘trim and fill’ method will
be conducted to explore the potential influence of a
publication bias [72]. Publication bias will not be
assessed by constructing funnel plot when < 10 studies
are available per primary outcome of interest, since the
plot for publication bias yields unreliable results [70].
Publication bias will be assessed using Stata V.14 (Stata
Corp., College Station, TX, USA).
Data synthesis
Statistical analysis
Pooled effects of continuous variables will be expressed
as Morris’s delta (Morris’s dppc), if the same primary out-
comes are used in the eligible studies. Morris described
a pre-post control effect size as “the mean pre-post
change in the treatment group minus the mean pre-post
change in the control group, divided by the pooled
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baseline standard deviation of both the treatment and
control groups” [75, 76]:
dppc ¼ cp
Mpost;T−Mpre;T
 
− Mpost;C−Mpre;C
 
SDpre
 
The pooled pretest standard deviation is calculated as
[75, 76]:
SDpre ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ðnT−1ÞSD2pre;TþðnC−1ÞSD2pre;C
nTþnC−2
q
T: treatment; C:
control
The small sample size bias-correction is calculated as
[75, 76]:
CP ¼ 1− 34 nT þ nC−2ð Þ−1
Effect size (Morris’s dppc) will be calculated using
Campbell Collaboration effect size calculator (http://
www.campbellcollaboration.org/escalc/html/EffectSize-
Calculator-SMD-main.php) and Psychometrica online tool
(https://www.psychometrica.de/effect_size.html#cohc). If
continuous outcomes measures are different between
studies, we will also express pooled effects with Morris’s
dppc, but we will first convert the different outcome mea-
sures to a 0 to 100 scale [65]. For the measurement of ef-
fect sizes three levels are defined: small effect size (dppc <
0.40), medium effect size (0.40 ≤ dppc ≤ 0.70) or large effect
size (dppc > 0.70). Although there are no available data for
minimally clinically important differences (MCIDs) for
pain and disability in adult patients with headache, a clin-
ically important effect for the primary outcomes is consid-
ered when the magnitude of the effect size is at least
medium [65]. Meta-analysis will be done separately on
studies with clinical trial design and on studies with com-
parative observational design. Additionally, meta-analyses
will be conducted separately on tension-type headache,
cervicogenic headache, and migraine within each study
design. In the presence of a sufficient number of studies,
we will also conduct a priori subgroup analysis based on
the overall risk of bias score (high, moderate, and low risk
of bias). All data from the meta-analyses with 95% confi-
dence intervals will be reported in forest plots. The
random-effect model with DerSimonian–Laird (D + L)
method [77] will be used to pool the data from individual
studies. Stata V.11 and V.14 (Stata Corp., College Station,
TX, USA) will be used for meta-analysis. Wherever applic-
able, NNT will be presented to help the reader better
understand how the results can be applied to the individ-
ual patient. The Campbell Collaboration effect size calcu-
lator and Psychometrica online tool will be used to
calculate NNT.
In addition, where a quantitative synthesis will not be
deemed suitable due to low number of studies, a qualita-
tive synthesis of results will be undertaken. We will
conduct meta-analysis when ≥2 studies are available
since “two” is the minimum number of studies required
for meta-analysis [78]. If meta-analysis is not possible,
we will summarize study results as either statistically sig-
nificant (p-value < 0.05) or nonsignificant and calculate
the effect of intervention on the outcomes of this study.
Unit of analysis issues
The unit of analysis will be based on aggregated out-
come data as individual patient data is not available for
any study.
Analysis problems
If sufficient homogeneous studies are available for statis-
tical pooling, a meta-analysis will be performed for the
time points: short (< 3 months after the baseline mea-
surements were taken), intermediate (at least 3 months
but < 12months after the baseline measurements were
taken) and long-term (12 months or more after the base-
line measurements were taken) follow-up. If multiple
time points fall within the same category, the one that is
closest to the end of the treatment, 6 and 12months will
be used [70].
Sensitivity analysis
Sensitivity analysis using the leave-one-out method will
be performed to determine the effect of each individual
study on the pooled results [79]. Furthermore, sensitivity
analyses will be conducted by using only high-quality
studies in the meta-analyses to explore the robustness of
conclusion. All sensitivity analysis will be performed
using Stata V.14 (Stata Corp., College Station, TX, USA).
Summary of evidence
The overall quality of the evidence and strength of the
recommendations for the primary outcomes will be
assessed using GRADE [80]. The ‘Summary of findings’
tables will be generated by the GRADE working group
online tool (GRADEpro GDT (www.gradepro.org)). The
downgrading process is based on five domains: study
limitations (e.g., risk of bias), inconsistency (e.g., hetero-
geneity between studies results), indirectness of evidence
(including other patient populations or use of surrogate
outcomes), imprecision (e.g., small sample size) and
reporting bias (e.g., publication bias). The quality of evi-
dence is classified as the following: (i) high quality—fur-
ther research is unlikely to change confidence in the
estimate of effect; the Cochrane criteria and NOS iden-
tify no risks of bias and all domains in the GRADE clas-
sification are fulfilled. In addition, further research is
unlikely to change confidence in the estimate of effect
(ii) moderate quality—further research is likely to have
an important impact on the confidence in the estimate
of effect, and one of the domains in the GRADE
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classification is not fulfilled; (iii) low quality—further re-
search is likely to have an important impact on the con-
fidence and may change the estimate; two of the
domains are not fulfilled in the GRADE classification;
and (iv) very low quality—we are uncertain about the es-
timate; three of the domains in the GRADE classification
are not fulfilled [70, 80].
Discussion
Headaches are one of the main reasons for absenteeism
from works or avoid physical and social activities [81].
From 2007 to 2017, the number of all-age years lived
with disabilities attributed to headaches increased by
15.4% (95% UI, 14.6–16.2) [2]. Tension-type headaches,
cervicogenic headaches, and migraines are three com-
mon types of headache which can have a considerable
impact on individuals’ quality of life. Physical therapy is
a treatment option that consists of interventions such as
manual therapy, electrotherapy, exercises, and various
maneuvers in order to improve pain, disability, and qual-
ity of life in patients with headaches. Dry needling is a
physical therapy modality that involves inserting a fine
filiform needle into the TrPs of soft tissues. There are
many theoretical models that have influenced physical
therapists and clinicians practicing dry needling [82].
The ‘fast-in-and-fast-out’ technique described by Hong
[44] is probably one of the most widely used for the
managements of neuromusculoskeletal pain and dys-
function [82].
Despite an increasing number of studies evaluating the
effectiveness of dry needling for musculoskeletal disor-
ders, no systematic review with meta-analysis has been
carried out to examine the effectiveness of dry needling
in patients with headaches. It is hoped that this study
will provide useful information for physical therapists
and clinicians on the treatment of tension-type head-
ache, cervicogenic headache, and migraine.
Limitations
This review will not capture any studies that assess the sec-
ondary outcomes (i.e., cervical spine ROM, frequency of
headaches, health-related quality of life, and TrPs tender-
ness) but did not report on pain or disability. Therefore, the
findings regarding the secondary outcomes will be limited
by the included studies based on the eligibility criteria.
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